This information was published on 2026-06-21T00:10:48 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2620223 |
| (220) |
20 Jan 2026
|
| (511) (510) |
Class 5
drugs for medical use; drugs for medical purposes; medicine; medicines for human purposes; pharmaceutical products for use by humans; pharmaceuticals; pharmaceutical drugs; pharmaceutical pills; hormones for medical use; hormones for medical purposes; therapeutic drugs and agents; pharmaceutical preparations containing hormones for humans; medicines; medicines for adjusting the menstrual cycle; pharmaceutical preparations; pharmaceutical and medical preparations; pharmaceutical preparations and substances; pharmaceutical preparations being hormone preparations for human use; a synthetic hormone for the treatment of infertility; a synthetic hormone for the prevention of miscarriage Class 44 healthcare; providing medical treatment; provision of medical treatment; medical treatment services provided by clinics and hospitals; providing healthcare services; prescription of medicines; medical, medicinal and pharmaceutical consultancy; medical services; medical clinic services; medical counselling; family planning services; medical treatment services; human fertility treatment services; fertility treatment; fertility treatment services; treatment of infertility; provision of medical information; healthcare services; medical and healthcare services; medicine information services; provision of health care information by telephone and the Internet; providing health information via a website; health counseling; provision of health care services; consultancy relating to healthcare; consultancy services relating to health |
| (540) | Delina |
| (550) | Word |
| (730) |
Anthia Life Sciences Pty Ltd
ACN/ABN 99679715863 |
| (750) |
Argyll Law
|
Find out more about publications on the About page.